Preclinical Characterization of the Anti-Leukemia Activity of the CD123 Antibody-Drug Conjugate, Pivekimab Sunirine (IMGN632)

被引：0
|
作者：
Cole, Frances M. [1 ]
Laszlo, George S. [2 ]
Lunn-Halbert, Margaret C. [1 ]
Kehret, Allie R. [1 ]
Zweidler-McKay, Patrick A. [3 ]
Rodriguez-Arboli, Eduardo [1 ,4 ]
Wu, David [5 ]
Nyberg, Kyle E. [1 ]
Li, Junyang [1 ]
Lim, Sheryl Y. T. [1 ]
Lakshmikanthan, Sribalaji [3 ]
Walter, Roland B. [6 ,7 ,8 ]
机构：
[1] Fred Hutchinson Canc Ctr, Translat Sci & Therapeut Div, Seattle, WA USA
[2] Fred Hutchinson Canc Ctr, 1100 Fairview Ave North, Seattle, WA USA
[3] ImmunoGen Inc, Waltham, MA USA
[4] Univ Seville, Hosp Univ Virgen del Rocio, Dept Hematol, Inst Biomed Sevilla, Seville, Spain
[5] Univ Washington, Hematopathol, Seattle, WA USA
[6] Fred Hutchinson Canc Ctr, Seattle, WA USA
[7] Univ Washington, Dept Med, Div Hematol & Oncol, Seattle, WA USA
[8] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-200907
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2751 / 2751
页数：1
相关论文
共 50 条
  • [1] The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia
    Watts, Ben
    Smith, Christopher M.
    Evans, Kathryn
    Gifford, Andrew J.
    Mohamed, Sara M. A.
    Erickson, Stephen W.
    Earley, Eric J.
    Neuhauser, Steven
    Stearns, Timothy M.
    Philip, Vivek M.
    Chuang, Jeffrey H.
    Zweidler-McKay, Patrick A.
    Lakshmikanthan, Sribalaji
    Jocoy, Emily L.
    Bult, Carol J.
    Teicher, Beverly A.
    Smith, Malcolm A.
    Lock, Richard B.
    HEMASPHERE, 2025, 9 (01):
  • [2] Pivekimab Sunirine (PVEK, IMGN632), a CD123-Targeting Antibody-Drug Conjugate, in Combination with Azacitidine and Venetoclax in Patients with Newly Diagnosed Acute Myeloid Leukemia
    Daver, Naval
    Montesinos, Pau
    Altman, Jessica K.
    Wang, Eunice S.
    Martinelli, Giovanni
    Roboz, Gail J.
    Begna, Kebede
    Vyas, Paresh
    Lunghi, Monia
    Platzbecker, Uwe
    Burke, Patrick W.
    Walter, Roland B.
    Advani, Anjali S.
    Garciaz, Sylvain
    Gastaud, Lauris
    Sallman, David A.
    Pemmaraju, Naveen
    Torres, Laura
    Abaza, Yasmin
    Chan, Onyee
    Kantarjian, Hagop M.
    Oshrine, Benjamin
    Du, Yining
    Malcolm, Kara
    Sweet, Kendra
    BLOOD, 2023, 142
  • [3] Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study
    Daver, Naval G.
    Montesinos, Pau
    Deangelo, Daniel J.
    Wang, Eunice S.
    Papadantonakis, Nikolaos
    Todisco, Elisabetta
    Sweet, Kendra L.
    Pemmaraju, Naveen
    Lane, Andrew A.
    Torres-Minana, Laura
    Thompson, James E.
    Konopleva, Marina Y.
    Sloss, Callum M.
    Watkins, Krystal
    Bedse, Gaurav
    Du, Yining
    Malcolm, Kara E.
    Zweidler-McKay, Patrick A.
    Kantarjian, Hagop M.
    LANCET ONCOLOGY, 2024, 25 (03): : 388 - 399
  • [4] CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia
    Angelova, Evgeniya
    Audette, Charlene
    Kovtun, Yelena
    Daver, Naval
    Wang, Sa A.
    Pierce, Sherry
    Konoplev, Sergej N.
    Khogeer, Haitham
    Jorgensen, Jeffrey L.
    Konopleva, Marina
    Zweidler-McKay, Patrick A.
    Medeiros, L. Jeffrey
    Kantarjian, Hagop M.
    Jabbour, Elias J.
    Khoury, Joseph D.
    HAEMATOLOGICA, 2019, 104 (04) : 749 - 755
  • [5] CD123 Expression Patterns and Potential of IMGN632, a CD123-Targeted Antibody Drug Conjugate, in Acute Lymphoblastic Leukemia
    Angelova, Evgeniya
    Audette, Charlene
    Kovtun, Yelena
    Daver, Naval
    Wang, Sa A.
    Pierce, Sherry
    Konoplev, Sergej Naumovich
    Jorgensen, Jeffrey L.
    Konopleva, Marina
    Zweidler-McKay, Patrick A.
    Kantarjian, Hagop M.
    Jabbour, Elias J.
    Khoury, Joseph David
    BLOOD, 2017, 130
  • [6] Pediatric preclinical testing consortium evaluation of the CD123 antibody drug conjugate, IMGN632, against xenograft models of pediatric acute lymphoblastic leukemia
    Evans, Kathryn
    El-Zein, Narimanne
    Jones, Connor
    Erickson, Stephen W.
    Guo, Yuelong
    Teicher, Beverly A.
    Adams, Sharlene
    Zweidler-McKay, Patrick A.
    Smith, Malcolm A.
    Lock, Richard B.
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Synergistic Anti-Leukemic Activity of PARP Inhibition Combined with IMGN632, an Anti-CD123 Antibody-Drug Conjugate in Acute Myeloid Leukemia Models
    Fritz, Claire
    Portwood, Scott M.
    Adams, Julie
    Cronin, Tara
    Lutgen-Dunckley, Linda
    Martens, Brandon L.
    Sloss, Callum M.
    Watkins, Krystal
    Kovtun, Yelena
    Adams, Sharlene
    Wang, Eunice S.
    BLOOD, 2018, 132
  • [8] Pediatric Preclinical Testing Consortium Evaluation of the Anti-CD123 Antibody-Drug Conjugate, IMGN632, Against Patient-Derived Xenograft Models of Pediatric Acute Lymphoblastic Leukemia
    Lock, Richard B.
    Evans, Kathryn
    Randall, Joanna
    Erickson, Stephen W.
    Earley, Eric J.
    Neuhauser, Steven
    Stearns, Tim
    Philip, Vivek
    Teicher, Beverly A.
    Watkins, Krystal
    Sloss, Callum M.
    Zweidler-McKay, Patrick A.
    Smith, Malcolm A.
    BLOOD, 2022, 140 : 8983 - 8984
  • [9] A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells
    Kovtun, Yelena
    Jones, Gregory E.
    Adams, Sharlene
    Harvey, Lauren
    Audette, Charlene A.
    Wilhelm, Alan
    Bai, Chen
    Rui, Lingyun
    Laleau, Rassol
    Liu, Fenghua
    Ab, Olga
    Setiady, Yulius
    Yoder, Nicholas C.
    Goldmacher, Victor S.
    Chari, Ravi V. J.
    Pinkas, Jan
    Chittenden, Thomas
    BLOOD ADVANCES, 2018, 2 (08) : 848 - 858
  • [10] IMGN632: A NOVEL ANTIBODY-DRUG CONJUGATE (ADC) OF A CD123-TARGETING ANTIBODY WITH A POTENT DNA-ALKYLATOR IS HIGHLY ACTIVE IN PRECLINICAL MODELS OF AML WITH POOR PROGNOSIS
    Kovtun, Y.
    Jones, G.
    Harvey, L.
    Rui, L.
    Audette, C.
    Liu, F.
    Bai, C.
    Wilhelm, A.
    Yoder, N. C.
    Adams, S.
    Goldmacher, V. S.
    Chari, R.
    Chittenden, T.
    HAEMATOLOGICA, 2016, 101 : 222 - 222
12345